Skip to main content
    V

    Verastem Inc (VSTM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.41
    -0.29 (-3.77%)

    Market Cap: $970.31M

    Last updated: Nov 17, 2026 at 4:35 PM ET

    Verastem Inc (VSTM) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Verastem (VSTM) has a market cap of $970.31M and an enterprise value of $916.94M. Revenue grew 2847.28% over the last 12 months from the 12 months before. Its share count is up 38.38% from a year earlier.

    Total Valuation

    Enterprise value is 5.50% below the market cap, as cash exceeds debt.

    Market Cap$970.31M
    Enterprise Value$916.94M
    Latest price (Nov 17, 2026)$7.41

    Key Dates

    The next earnings report is expected on Mar 2, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 2, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 1.12% in the quarter ended Sep 30, 2026 and grew 58.58% a year over 2 years.

    Shares Outstanding101.24M
    Shares Change (YoY)+38.38%
    Shares Change (QoQ)+1.12%
    Share Count Growth (2Y CAGR)+58.58%

    Valuation Ratios

    Sales and book value multiples are 7.5x and 74.3x. Its year-end P/S ranged from 3.9x to 179.7x from 2018 to 2025.

    P/S Ratio7.5x
    Forward P/S9.0x
    P/B Ratio74.3x

    Valuation history and multiples

    Price Statistics

    The stock is down 1.92% over 52 weeks and trades 12.41% below its 50-day average.

    Beta (1Y)1.06
    52-Week Change-1.92%
    1-Month Change-14.04%
    3-Month Change+1.58%
    6-Month Change+78.55%
    5-Year Change-68.76%
    10-Year Change-35.03%
    Total Return (1Y)-1.92%
    Total Return (3Y CAGR)+5.39%
    Total Return (5Y CAGR)-27.07%
    Return vs SPY (1Y)-31.62%
    Max Drawdown (1Y)-67.58%
    Max Drawdown (3Y)-84.36%
    Sharpe Ratio (1Y)-0.32
    Correlation with SPY (1Y)0.21
    50-Day Average$8.46
    200-Day Average$6.31
    52-Week Range$3.43 to $10.82
    RSI (14 Days)35.1
    Average Volume (20 Days)3.18M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.93x current liabilities, and total debt is 11.82x shareholder equity.

    Current Ratio1.93x
    Quick Ratio1.91x
    Debt / Equity11.82x
    Interest Coverage-132.21x

    Returns and Efficiency

    Return on invested capital is -110.39% over the last 12 months, against a 5-year average of -89.92%.

    Return on Equity (ROE)-1771.14%
    Return on Assets (ROA)-77.91%
    Return on Invested Capital (ROIC)-110.39%
    Return on Capital Employed (ROCE)-143.29%
    ROA (5Y Average)-83.04%
    ROIC (5Y Average)-89.92%
    Asset Turnover0.49x
    Inventory Turnover5.51x
    Receivables Turnover5.18x
    Cash Conversion Cycle-408 days

    Scores

    VSTM has an Altman Z-Score of -7.60, in the distress zone below 1.81, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score-7.60
    Altman Z ZoneDistress
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $100.30M over the last 12 months.

    Revenue$100.30M
    Revenue Growth (YoY)+2847.28%
    Gross Profit$87.48M
    Operating Income-$194.31M
    Pretax Income-$354.64M
    Net Income-$178.90M
    EBITDA-$180.09M
    EBIT-$180.99M
    Reported EPS (TTM)-$1.98

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 4.40% of the $229.64M in total assets.

    Cash and Equivalents$172.80M
    Total Debt$119.43M
    Net Cash$53.37M
    Net Cash Per Share$0.53
    Working Capital$96.05M
    Shareholder Equity$10.10M
    Book Value Per Share$0.10
    Tangible Book Value-$5.49M
    Total Assets$229.64M
    Total Liabilities$219.54M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$159.57M
    FCF Per Share-$1.32
    Depreciation and Amortization$901.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -193.73%.

    Gross Margin87.23%
    Operating Margin-193.73%
    Pretax Margin-353.60%
    Net Margin-178.38%
    EBITDA Margin-179.56%
    EBIT Margin-180.46%

    Growth

    Revenue grew 128.36% a year over 3 years.

    Revenue Growth (3Y CAGR)+128.36%
    Revenue Growth (5Y CAGR)-18.97%
    Book Value Per Share Growth (2Y CAGR)-43.39%
    Tangible Book Per Share Growth (2Y CAGR)-52.21%

    Revenue and profit by year

    Dividends and Yields

    VSTM does not pay a dividend.

    Buyback Yield-16.75%
    Shareholder Yield-16.75%

    Stock Splits

    The last split was a 1-for-12 reverse split on Jun 1, 2023.

    Last Split DateJun 1, 2023
    Split TypeReverse split
    Split Ratio1:12

    Peer Position

    Against 7 similar companies, VSTM has the 3rd highest P/S.

    P/S Ratio7.5x vs 3.8x median
    ROIC-110.39% vs -65.05% median
    Revenue Growth (Trailing 4 Quarters, YoY)+2847.28% vs -18.95% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 116.29% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+116.29%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About VSTM

    What is VSTM's market cap?

    Verastem has a market cap of $970.31M. Its enterprise value, which adds debt and subtracts cash, is $916.94M.

    How many shares of VSTM are outstanding?

    Verastem has 101.24M shares outstanding. The count is up 38.38% from a year earlier.

    Does VSTM pay a dividend?

    No. Verastem does not pay a dividend.

    How much debt does VSTM have?

    Verastem has $119.43M of total debt and $172.80M of cash and equivalents, a net cash position of $53.37M.